SC 13G/A: Cactus Acquisition Corp. 1 Ltd

AI Summary

SC 13G/A filing by Cactus Acquisition Corp. 1 Ltd.

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.0001 — er) Class A ordinary shares, par value $0.0001 per share (Title of Class of Securiti

Filing Documents

• ea0206693-13ga1cact_cactus1.htm (SC 13G/A) — 90KB
• 0001213900-24-046066.txt ( ) — 92KB

(a)

Item 1(a). Name of Issuer: The name of the issuer is Cactus Acquisition Corp. 1 Limited (the “ Issuer ”).

(b)

Item 1(b). Address of Issuer’s Principal Executive Offices: The Issuer’s principal executive offices are located at 4B Cedar Brook Drive, Cranbury, NJ 08512 .

(a)

Item 2(a). Name of Person Filing: The following entities, listed in (i) and (ii) below, who are filing this Amendment No. 1 (this “ Amendment ”) to the Statement of Beneficial Ownership on Schedule 13G filed on March 21, 2022 (the “ Statement ”), are referred to herein collectively as the “ Reporting Persons ”: (i) Cactus Healthcare Management LP (the “ Sponsor ”) (ii) Cactus Healthcare Management LLC (the “ GP ”) The Sponsor directly holds the securities of the Issuer that are reported in this Statement. The GP serves as the sole general partner of the Sponsor and may therefore be deemed to share voting and investment authority with respect to the securities of the Issuer held thereby . Each of Hibotan LLC (an affiliate of Israel Biotech Fund), Kalistcare Limited (an affiliate of Consensus Business Group), and Clal Biotechnology Industries Cactus Ltd. (an affiliate of Clal Biotechnology Industries Ltd.) holds an equal 33.33% equity interest in the GP. No single entity or individual possesses the ability to control the voting or investment decisions made by the GP.

(b)

Item 2(b). Address of Principal Business Office or, if None, Residence: The principal business office of each Reporting Person is c/o Cactus Acquisition Corp. 1 Limited, 4B Cedar Brook Drive, Cranbury, NJ 08512.

(c)

Item 2(c). Citizenship: The citizenship or state of organization, as applicable, of each Reporting Person is as follows: (i) Sponsor— Delaware (ii) GP— Delaware

(d)

Item 2(d). Title of Class of Securities: Class A ordinary shares, par value $0.0001 per share, of the Issuer (“ Class A ordinary shares ”).

(e)

Item 2(e). CUSIP Number: The CUSIP number of the Class A ordinary shares is G1745A108. CUSIP No. G1745A108 13G/A Page 5 of 8 Pages Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: _________________ Not applicable. Item 4. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. I. Cactus Healthcare Management LP (a) Amount beneficially owned: 632,501 (1) (b) Percent of class*: 12.5 % (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 632,501 (1) (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose of or to direct the disposition o

View Full Filing

View this SC 13G/A filing on SEC EDGAR